One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Uses of hydroxychloroquine Chloroquine in vivo Hydroxychloroquine plaquenil uses Can ranitidine be taken with plaquenil And screening tests, but that screening begins after one year of therapy for all patients on chloroquine. Screening may be best incorporated into the hospital eye service via virtual clinics. The results of screening should be communicated back to the prescribing doctor, patient and GP as normal, possible or definite hydroxychloroquine retinopathy. Retinal screening service will be provided by STH Ophthalmology department As patients are started on hydroxychloroquine, they will have a baseline retinal screen usually at 3 months but certainly within 12 months of starting, organised by the specialist. The specialist will also arrange a follow up retinal screen after 5 years Plaquenil Toxicity Screening Plaquenil Toxicity Screening Plaquenil Toxicity Screening Hydroxychloroquine Sulphate Plaquenil medication has been effectively used for many years for a variety of infectious and autoimmune conditions, including rheumatoid Arthritis RA and Systemic Lupus Erythematosus SLE. On rare occasion, and usually after many years, Plaquenil can damage the central. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Plaquenil retina screening guidelines Recommendations on Screening for Chloroquine and., Hydroxychloroquine and Retinal Screening Plaquenil eye exam how oftenPlaquenil medicine side effectsCan i take plaquenil and prednisone at the same timeAralene Mar 01, 2011 New Screening Guidelines for Hydroxychloroquine Toxicity Experts explain their role in clinical practice. Stephen G. Schwartz, MD, MBA • William F. Mieler, MD. Hydroxychloroquine Plaquenil, Sanofi-Aventis remains widely used in the treatment of various rheumatologic disorders. Retinal Physician - New Screening Guidelines for.. Plaquenil Toxicity Screening - Retina Group of New York. Hydroxychloroquine And Chloroquine Screening 2016 AAO.. In 2011 the American Academy of Ophthalmology published new clinical guidelines for appropriate annual screenings for those patients taking Plaquenil. These guidelines are much different from the previous 2002 recommendations, and many practicing doctors were trained with the 2002 guidelines in mind. If we extrapolate the use of long-term hydroxychloroquine at KPNC to the entire US population, approximately 350 000 patients should receive annual eye screening by current guidelines. 9 Therefore, screening for hydroxychloroquine retinal toxicity is an important economic and patient safety issue. Retinal toxicity from hydroxychloroquine use. Retinal photograph showing classic “bull’s eye” retinopathy of hydroxychloroquine toxicity, which represents atrophy of the retinal pigment epithelium. This is a relatively late change, and good screening can detect toxicity before any bull’s eye is visible.